secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0001104659-22-068072
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood shareholders elect 9 directors, approve say-on-pay, ratify E&Y at 2022 meeting
--------------------------------------------------------------------------------

- Nine director nominees elected with votes for ranging from ~110.1M to ~124.3M; Alexander Denner received most withheld (~15.9M).
- Say-on-pay advisory vote passed: ~122.3M for, ~3.4M against, ~393,566 abstain.
- Ratification of Ernst & Young as independent auditor for 2022 approved: ~131.9M for, ~2.7M against, ~109,800 abstain.
- Broker non-votes of 8,607,404 on first two items and none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465922068072/0001104659-22-068072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465922068072/tm2217575d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-068072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer